China Shenghuo Finalizes Settlement of Securities Class Action

Washington, DC: China Shenghuo Pharmaceutical Holdings, Inc. (China Shenghuo) (AMEX: KUN) announced today the final approval by the court of a settlement agreement resolving and dismissing all claims asserted against the company in the consolidated securities class action lawsuit, Varghese, et al v. China Shenghuo Pharmaceutical Holdings, Inc., et al. The substantive allegations of the amended consolidated complaint have previously been summarized in SEC disclosures by China Shenghuo.

China Shenghuo is contributing US $200,000 towards a total settlement fund of $600,000.

Legal Help

If you have a similar problem and would like to be contacted by a lawyer at no cost or obligation, please fill in our form.
Published on Mar-24-11